{"id":282410,"date":"2024-10-19T19:05:32","date_gmt":"2024-10-19T19:05:32","guid":{"rendered":"https:\/\/pdfstandards.shop\/product\/uncategorized\/bs-iso-200692019\/"},"modified":"2024-10-25T15:48:07","modified_gmt":"2024-10-25T15:48:07","slug":"bs-iso-200692019","status":"publish","type":"product","link":"https:\/\/pdfstandards.shop\/product\/publishers\/bsi\/bs-iso-200692019\/","title":{"rendered":"BS ISO 20069:2019"},"content":{"rendered":"

This document provides guidance for assessment and evaluation of planned changes to drug delivery systems that are integral with, packaged with, or cross-labelled for use with a specified medicinal product. This document is applicable to the drug delivery system\u2019s lifecycle from registration clinical studies to end-of-life. This document is applicable to the assessment of changes within the following drug delivery systems:<\/p>\n

\u2014 needle-based injection systems for medical use;<\/p>\n

\u2014 aerosol drug delivery devices;<\/p>\n

\u2014 needle-free injectors for medical use.<\/p>\n

\n
\n NOTE\n <\/div>\n

These are covered by the ISO 11608 series, ISO 20072 and ISO 21649, respectively.<\/p>\n<\/p><\/div>\n

This document might also be useful for assessing and evaluate changes to other drug delivery devices or systems.<\/p>\n

Examples of changes that are within the scope of this document include but are not limited to the following:<\/p>\n

    \n